BillionToOne, Inc. (BLLN) stock
BLLNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$90.20−1.34 (-1.46%)
Close on Nov 19, 2026Market cap $4.26BP/E –Yield –
BillionToOne revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
BillionToOne's revenue for the twelve months ending Sep 30, 2026 was $436.87M, up 71.9% year over year. For fiscal 2025 it was $305.11M, up 100.0% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $305.11M | +100.0% |
| FY2024 | Dec 31, 2024 | $152.58M | +112.7% |
| FY2023 | Dec 31, 2023 | $71.73M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $122.98M | +47.2% |
| Q2 FY2026 | Jun 30, 2026 | $109.45M | +64.4% |
| Q1 FY2026 | Mar 31, 2026 | $108.39M | +83.8% |
| Q4 FY2025 | Dec 31, 2025 | $96.05M | +113.1% |
| Q3 FY2025 | Sep 30, 2025 | $83.52M | +117.4% |
| Q2 FY2025 | Jun 30, 2025 | $66.57M | – |
| Q1 FY2025 | Mar 31, 2025 | $58.96M | – |
| Q4 FY2024 | Dec 31, 2024 | $45.08M | – |
| Q3 FY2024 | Sep 30, 2024 | $38.42M | – |
See a number that looks wrong?